ArticlePloS one2026
Automatic early detection of pathological signs following primary total hip arthroplasty using radiographs, clinical scores, and comorbidities.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence in Arthroplasty: A Comprehensive Structured Critical Review and Descriptive Evidence Map of Validation, Uncertainty, and Workflow Integration.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing prevalence of total hip arthroplasty (THA) revisions, along with their generally poorer outcomes compared to primary procedures, emphasizes the urgent need for early detection of primary THA failure. This study proposes a model that integrates radiographic, clinical, and comorbidity data to automatically detect pathological signs within one year after primary THA. The dataset included two independent patient cohorts: the first comprised 400 patients, leading to 801 radiographs with pathological signs and 785 without; the second included 155 patients, resulting in 417 radiographs with pathological signs and 508 without. After preprocessing, the dataset was split into training, validation, and test sets. Three models were developed, one for each data type. A deep learning framework was applied to the radiographic data, while multiple machine learning classifiers were trained on the clinical and comorbidity data. Predictive probabilities were obtained for each subset and data type, and the final combined model was generated by averaging the predicted probabilities from all individual models. The final combined model achieved an F1 score of 0.72 (95% CI: 0.65-0.79), a balanced accuracy of 0.69 (95% CI: 0.63, 0.77), and an area under the curve (AUC) of 0.72 (95% CI: 0.65, 0.79) on the internal test set. On the external validation set, it achieved an F1 score of 0.66 (95% CI: 0.62, 0.70), a balanced accuracy of 0.62 (95% CI: 0.59, 0.66), and an AUC of 0.67 (95% CI: 0.62, 0.72). The results demonstrate the potential of the developed approach to automatically detect early pathological signs of THA, enabling virtual follow-up and potentially reducing the burden on clinicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.